Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Apis Biotechnology is a China-based high-tech life science company focused on the development, production, and sale of biochemical reagents and raw materials rather than a traditional therapeutic drug pipeline. Its core business includes enzymes, coenzymes, antigens, antibodies, buffers, substrates, media, dyes, amino acids, and other inputs used in in vitro diagnostics, biopharma manufacturing, genomic research, and laboratory applications. The company also serves food safety and animal disease testing markets and has offered custom synthesis capabilities for IVD customers. Public Chinese corporate records indicate the company remains active and operates from Beijing Economic-Technological Development Area. Available sources do not indicate a substantive clinical-stage therapeutics pipeline; the business appears primarily tools, reagents, and diagnostic-input oriented.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Apis Biotechnology.